(Q55035469)

16 June 2018

title

Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention. (English)

1 reference

16 June 2018

1 reference

Filiz Kizilirmak

1

1 reference

16 June 2018

Haci Murat Gunes

2

1 reference

16 June 2018

Gultekin Gunhan Demir

3

1 reference

16 June 2018

Tayyar Gokdeniz

4

1 reference

16 June 2018

Ekrem Guler

5

1 reference

16 June 2018

Beytullah Cakal

6

1 reference

16 June 2018

Mehmet Onur Omaygenç

7

1 reference

16 June 2018

Fatih Yılmaz

8

1 reference

16 June 2018

Umeyir Savur

9

1 reference

16 June 2018

Irfan Barutcu

10

1 reference

16 June 2018

publication date

1 December 2015

1 reference

16 June 2018

Cardiovascular Drugs and Therapy

published in

1 reference

16 June 2018

volume

29

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

page(s)

519-526

1 reference

16 June 2018

Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Frequency and long-term impact of myonecrosis after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Recognition of the importance of embolization in atherosclerotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Society of cardiac angiography and interventions: Suggested management of the no‐reflow phenomenon in the cardiac catheterization laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Myonecrosis after revascularization procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: review of the current data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6631-4

10.1007/S10557-015-6631-4

21 January 2018

Identifiers

DOI

1 reference

16 June 2018

1 reference

16 June 2018